Journal profile · CARDIAC & CARDIOVASCULAR SYSTEMS
Cardiology and Therapy
ISSN 2193-8261 · eISSN 2193-6544 · Adis, Springer Healthcare · United Kingdom · 4 issues per year
Cardiology and Therapy: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 3.2 (journal website); fully open access; APC about USD 7,675; median 70 days to acceptance (85 articles, last 24 months); 49 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
Cardiology and Therapy is published by Adis, Springer Healthcare and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Atrial Fibrillation Management and Outcomes, Antiplatelet Therapy and Cardiovascular Diseases and Cardiac Valve Diseases and Treatments, together about 22.4% of its articles. Its main subfields are Cardiology and Cardiovascular Medicine. (generated from OpenAlex topic counts and CAS ranking data)
Aims and ScopeCardiology and Therapy is an international, open access, peer reviewed (single-blind), rapid-publication journal dedicated to the publication of high-quality clinical (all phases), observational, real-world, and health outcomes research around the discovery, development, and use of cardiovascular therapies and interventions, including devices. Studies relating to diagnosis and diagnostics, pharmacoeconomics, public health, quality of life, as well as patient care, management and education are also encouraged. Areas of focus include, but are not limited to, ischaemic heart disease and acute cardiac care, myocardial, valvular, pericardial and congenital heart disease, vascular and pulmonary disease (including hypertension), arrhythmias, heart failure, non-invasive diagnostic techniques, and invasive and interventional cardiology as well as cardiovascular surgery. The journal is of interest to a broad audience of pharmaceutical and healthcare professionals and publishes original research, reviews, case reports/case series, trial protocols and short communications such as commentaries and editorials. Cardiolology and Therapy will consider all scientifically sound research be it positive, confirmatory or negative data. Submissions are welcomed whether they relate to an international and/or a country-specific audience, something that is crucially important when researchers are trying to target more specific patient populations. This inclusive approach allows the journal to assist in the dissemination of quality research, which may be considered of insufficient interest by other journals.Rapid PublicationThe journal aims for a 2-week peer review, and 3-4 weeks from acceptance to online. Please note that for any steps outside of our standard publication processes, such as multiple rounds of peer review or article proofs, or non-standard copyright requests, this may delay publication beyond these timelines. The rapid timelines are achieved through the combination of a dedicated in-house editorial team, who manage article workflow, and an extensive Editorial and Advisory Board who assist with peer review. This allows the journal to support the rapid dissemination of research, whilst still providing robust peer review. Combined with the journal’s open access model this allows for the rapid, efficient communication of the latest research and reviews, fostering the advancement of cardiovascular therapies. Personal ServiceThe journal’s dedicated in-house e
From the journal's Aims & Scope
Research area (LetPub): CARDIAC & CARDIOVASCULAR SYSTEMS
Editor-in-chief Anthony A. BavryPublisher website
Editorial board by country: 1 in mainland China (about 1%); most named United States 25, Italy 10, United Kingdom 6, Germany 6, Brazil 4 (76 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Atrial Fibrillation Management and OutcomesMedicine9%
- Antiplatelet Therapy and Cardiovascular DiseasesMedicine7.2%
- Cardiac Valve Diseases and TreatmentsMedicine6.2%
- Heart Failure Treatment and ManagementMedicine6.1%
- Acute Myocardial Infarction ResearchMedicine6%
- Cardiac Imaging and DiagnosticsMedicine5.4%
- Coronary Interventions and DiagnosticsMedicine5.3%
- Lipoproteins and Cardiovascular HealthMedicine5.2%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Cardiac & Cardiovascular Systems | Zone 3 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Cardiac & Cardiovascular Systems | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
EmbasePublisher website
Other: Google Scholar, EBSCO, ProQuest, Dimensions, CNKI, Baidu, Naver, OCLC, Portico, CLOCKSS, Semantic Scholar
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher) 2025
- 3.2Publisher website ·
- 5-year impact factor (publisher) 2025
- 3.3Publisher website ·
- CiteScore 2026-06
- 5.5LetPub ·
- SJR 2026-06
- 1.01LetPub ·
- SNIP 2026-06
- 1.15LetPub ·
- h-index
- 38OpenAlex ·
- i10-index
- 174OpenAlex ·
- 2-year mean citedness
- 4.02OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 43LetPub ·
- Articles per year (publisher)
- 2,025Publisher website ·
- Downloads per year (publisher) 2025
- 424,400Publisher website ·
Articles by year OpenAlex count · 473 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 34 | 34 | 4 |
| 2025 | 49 | 49 | 145 |
| 2024 | 49 | 49 | 382 |
| 2023 | 47 | 47 | 404 |
| 2022 | 45 | 45 | 715 |
| 2021 | 41 | 41 | 867 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
70 daysMedian, submission to acceptance · P25–P75 54 days – 92 days
- Acceptance to online
- median 28 days (85 articles)
- Submission to online
- median 99 days
- Sample
- 85 articles with submission and acceptance dates (95 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 6 weeksLetPub ·
- Submission to first decision
- 2 daysPublisher website ·
- Acceptance to publication
- 28 daysPublisher website ·
- Submission to publication (journal-reported)
- about 6 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | EUR 5,950 / USD 7,675 / GBP 5,120 | Yes | CC BY-NC | |
| OpenAlex | USD 7,400 / EUR 5,750 / GBP 4,900 | — | — | |
| LetPub | GBP 4,700 / USD 6,850 / EUR 5,500 | Yes | — | |
| Publisher website | EUR 5,950 / USD 7,675 / GBP 5,120 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Policy excerpts from the journal's websiteOpen access, Preprints
- Open access Open access publishing
To find out more about publishing your work Open Access in Cardiology and Therapy, including information on fees, funding and licences, visit our Open access publishing page.
Source ↗Publisher website ·- Preprints Preprints
We encourage posting of preprints of primary research manuscripts on preprint servers, authors’ or institutional websites, and open communications between researchers whether on community preprint servers or preprint commenting platforms. Posting of preprints is not considered prior publication and will not jeopardize consideration in our journals. Authors should disclose details of preprint posti…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Adis, Springer Healthcare
- Country or region
- United Kingdom
- Language
- English
- Frequency
- 4 issues per year
- ISSN
- 2193-8261
- Electronic ISSN
- 2193-6544
- Latest issue on the website
- Volume 15, Issue 3 (September 2026)
- Official links
- Journal homepage ↗DOAJ
- Submission system ↗LetPub
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Cardiology and Therapy
What CAS zone is Cardiology and Therapy in?
In the 2025 upgraded edition of the CAS Journal Ranking, Cardiology and Therapy is in Zone 3 of Medicine, and in Zone 3 of the minor category Cardiac & Cardiovascular Systems. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Cardiology and Therapy?
The journal's website gives an impact factor of 3.2 (2025); this is the journal's own figure, as LetPub lists none for it; CiteScore 5.5, h-index 38.
How long does peer review take at Cardiology and Therapy?
Based on the dates recorded on 85 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 70 days (interquartile range 54–92 days); authors report an average review time of about 6 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of Cardiology and Therapy based?
Of the 76 board members whose country the journal's board page names, 1 (about 1%) are in mainland China; the countries named most often are United States (25), Italy (10) and United Kingdom (6). Counted from the institutions listed on the board page; for reference only.
Which databases index Cardiology and Therapy?
According to LetPub and DOAJ records, Cardiology and Therapy is indexed in ESCI, Scopus and DOAJ. The journal's website also lists Embase; that list has not been checked against each database.
Is Cardiology and Therapy open access, and what is the APC?
Cardiology and Therapy is a fully open-access journal. APC about USD 7,675.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .